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Abstract
Members of the T-box family of transcription factors are important regulators orchestrating the complex
regionalization of the developing mammalian heart. Individual mutations in Tbx20 and Tbx3 cause distinct congenital
heart abnormalities in the mouse: Tbx20 mutations result in failure of heart looping, developmental arrest and lack of
chamber differentiation, while hearts of Tbx3 mutants progress further, loop normally but show atrioventricular
convergence and outflow tract defects. The two genes have overlapping areas of expression in the atrioventricular
canal and outflow tract of the heart but their potential genetic interaction has not been previously investigated. In this
study we produced compound mutants to investigate potential genetic interactions at the earliest stages of heart
development. We find that Tbx20; Tbx3 double heterozygous mice are viable and fertile with no apparent
abnormalities, while double homozygous mutants are embryonic lethal by midgestation. Double homozygous mutant
embryos display abnormal cardiac morphogenesis, lack of heart looping, expression patterns of cardiac genes and
time of death that are indistinguishable from Tbx20 homozygous mutants. Prior to death, the double homozygotes
show an overall developmental delay similar to Tbx3 homozygous mutants. Thus the effects of Tbx20 are epistatic to
Tbx3 in the heart but Tbx3 is epistatic to Tbx20 with respect to developmental delay.
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Introduction
The four-chambered mammalian heart develops from a
simple linear heart tube by polar elongation, myocardial
differentiation and morphogenesis. This complex
regionalization of the developing heart is orchestrated by
multiple signaling modules and transcriptional circuits.
Members of the T-box family of transcription factors are
particularly important regulators of myocardial proliferation and
patterning. T-box family members Tbx1, Tbx2, Tbx3, Tbx5,
Tbx18 and Tbx20 are expressed in the heart and regulate
various aspects of embryonic heart development. The
importance of unperturbed T-box gene function is highlighted
by mutations in mice and human, which are associated with
congenital heart disease [1–3]. Patients heterozygous for
mutations in the coding region of TBX20 suffer from diverse
cardiac defects, including ventricular septal defects, aberrant
valvulogenesis, tetralogy of Fallot and cardiomyopathy [4–7].
Mutations in TBX3 result in the ulnar-mammary syndrome in
which a subset of patients has ventricular septal defects [8] or
conduction defects [9].
In the mouse, Tbx20 is expressed throughout the first heart
field, in a subset of second heart field progenitors and at later
stages in the endocardium and derived mesenchyme of the
atrioventricular and outflow tract (OFT) cushions and the
atrioventricular septum [10–13]. Following heart looping, Tbx20
expression decreases in the chamber myocardium compared
with atrioventricular and cardiac outflow regions [11,12].
Several studies show that mice lacking Tbx20 die early during
development and display short, severely underdeveloped heart
tubes that fail to undergo looping [3,13–15]. Failure in the
deployment or recruitment of the second heart field is likely a
contributing factor to this phenotype, since elongation of the
heart tube is primarily achieved by recruitment of cardiac
progenitors originating from the second heart field rather than
by proliferation. The expression pattern of Tbx20 is compatible
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with both cell-autonomous and non-cell-autonomous defects of
this process. Chamber myocardial genes are not activated in
Tbx20 deficient hearts while Tbx2, which is normally restricted
to the atrioventricular canal (AVC) and OFT, is ectopically
expressed throughout the cardiac crescent and linear heart
tube [3,13–15]. Tbx20 heterozygous mice survive postnatally
but show dilated cardiomyopathy, which phenocopies at least a
subset of human TBX20 mutant defects [3].
In the mouse heart, Tbx3 expression is first detected in the
inflow tract at the onset of heart looping. Its expression
delineates the developing cardiac conduction system,
endocardial cushions in the AVC, and the mesenchyme of the
OFT [16,17]. Tbx3 enables development of the cardiac
conduction system by restricting cell division and repressing
the chamber-specific gene expression program. Tbx3 deficient
embryos are developmentally retarded and die at midgestation
apparently due to yolk sac deficiencies although Tbx3 mutant
hearts are also abnormal [18,19]. Tbx3 deficiency results in
variable heart defects including increased cell division in the
atrioventricular canal, incomplete ventricular septation, double
outlet right ventricle, and delayed aortic arch formation.
Homozygous mutants also show a failure of atrioventricular
convergence, the process by which the inflow region is
displaced dorsally to the ventricular segment during heart
looping [19,20].
Thus, when individually mutated, Tbx20 and Tbx3 cause
distinct congenital heart abnormalities, but their overlapping
expression in the AVC and outflow tract in the developing heart
raises the question of whether they act independently or
through transcriptional regulation of common target genes.
Tbx20 expression appears ectopically in the apex of the
ventricular septum of Tbx3 mutant hearts at E12.5 [10] and
Tbx3 expression is markedly down regulated at E9.5 in the
AVC of embryos with a conditional deletion of Tbx20 [21].
However, the potential genetic interaction between these two
genes has not been investigated with respect to phenotypic
effects. In this study, we investigated the phenotype of Tbx20;
Tbx3 double homozygous mutants to explore possible genetic
interaction between these two genes based on their
overlapping expression in the AVC and OFT. With respect to
heart development, the double homozygous phenotype was
indistinguishable from that of the Tbx20 single homozygous
mutant in that heart looping and development was arrested
early in development. In addition, a general developmental
delay characteristic of Tbx3 homozygous mutants was
apparent in the double homozygous mutants, apparently
independent of the cardiac phenotype.
Materials and Methods
Mice
All experiments were carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health under
protocols approved by the Columbia University Institutional
Animal Care and Use Committee (protocol No. AC-
AAAD3302). Mutant alleles were maintained on a mixed
genetic background derived from 129, C57BL/6Tac and ICR
mice. Mice heterozygous for a null mutation of the Tbx20 locus,
Tbx20lacZ [3], hereafter designated as Tbx20-, or a null mutation
of the Tbx3 locus, Tbx3tm1Pa [18], hereafter designated as
Tbx3-, were intercrossed to produce double heterozygotes,
which were intercrossed to generate double homozygotes as
well as other genetic combinations. Embryos and weanling
mice were genotyped for Tbx20 and Tbx3 by PCR from lysates
of yolk sac or tail tip, respectively. The mutant allele of Tbx20
was genotyped with primers: Primer 1 (LoxP F2): 5’-
GACTGGAGAGGCCATCAAAA-3’ and Primer 2 (LacZR2): 5’-
GTTTTCCCAGTCACGACGTT- 3’; and the wild type allele was
genotyped with primers: T20 wt sense: 5”-
CCCAAGGAGAAGGAGGCAGCAGAGAAC-3’ and T20 wt
antisense: 5’- CGCAAGTATAAAATGGGGGTTCCTGACC-3’.
PCR conditions were 3 minutes at 94oC, 30 cycles (30 seconds
at 94oC, 30 seconds at 61oC, 60 seconds at 72oC), and 5
minutes at 72oC. The primers and PCR conditions for Tbx3
were as previously described [18].
Embryo collection and in situ hybridization
For timed pregnancies, females were placed with males
overnight and checked the following morning for the presence
of vaginal plugs. Noon on the day of the plug was designated
E0.5. Embryos between E8.5 and E9.25 were dissected out of
the uteri and their extra-embryonic membranes in phosphate
buffered saline (PBS) with 0.2% bovine serum albumin and
were fixed in 4% paraformaldehyde in PBS overnight. Standard
procedures were used for whole mount in situ hybridization
[22].
Statistics
Statistical analyses were performed using the Chi-square
distribution, Mann Whitney U test and notched box plot
analysis (Excel, Graph Pad Prism and R http://www.wessa.net/
rwasp_notchedbox1.wasp).
Results
Generation of Tbx20-/-; Tbx3-/- double homozygous
mutants
Mice heterozygous for Tbx20- or Tbx3- were intercrossed to
generate compound heterozygotes, Tbx20+/-; Tbx3+/-, which
were viable and fertile and present at the expected Mendelian
frequency at weaning (Χ2=4.08; p>0.10; Table 1). No apparent
abnormalities were observed. Compound heterozygotes were
intercrossed and embryos of all possible genotypes were
recovered at midgestation at the expected Mendelian
frequency (Χ2 = 14.38; p>0.05; Table 1).
Embryonic lethality and abnormal cardiac
morphogenesis in Tbx20; Tbx3 compound mutant
embryos
At E8.5 and E9.25, embryos (n=210) from heterozygous
matings were scored for heart looping and other morphological
and developmental features. Of these, 126 embryos were
generated by double heterozygous intercrosses while 84
embryos were generated by crossing Tbx20+/-; Tbx3+/- double
Tbx20 and Tbx3 in Early Mouse Heart Development
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heterozygotes to single heterozygotes. All embryos
homozygous mutant for Tbx20, including Tbx20-/-; Tbx3+/+
(n=27), Tbx20-/-; Tbx3+/- (n=29), as well as double homozygous
mutant embryos (n=14), were morphologically indistinguishable
from one another at any given developmental stage: Starting at
the heart looping stage, heart tube formation was retarded,
hearts were small, and heart looping failed, resulting in two
vertically oriented chamber-like swellings with a characteristic
hour-glass shape by E9.25 (Figure 1A–C and Tables 2 & 3), as
previously described for Tbx20-/- hearts [3,13–15]. Embryos
that were Tbx20+/-; Tbx3-/-, on the other hand, initiated heart
looping normally but some displayed atrioventricular
Table 1. Number of offspring of each genotype from
intercrosses of Tbx20 and Tbx3 heterozygotes, recovered
at weaning, and from crosses of mice double heterozygotes
for both genes, recovered at midgestation.
Cross Genotypes Total
 Tbx20 +/+ +/- +/+ +/- -/- -/- +/+ +/- -/-  
 Tbx3 +/+ +/+ +/- +/- +/+ +/- -/- -/- -/-  
Tbx20+/- x Tbx3+/-  28 23 18 16      85*
Tbx20+/-; Tbx3+/- x
Tbx20+/-; Tbx3+/-  11 15 13 30 12 21 6 6 12 126
**
*. Recovered and genotyped at weaning.
**. Recovered and genotyped E8.5 - E9.25.
convergence defects by E9.25 (2/4) similar to Tbx3-/- embryos
(4/4) (Figure 1E–G and Table 3), as previously described [19].
Wild type and single or double heterozygotes had normal heart
morphology (n=120).
Limb abnormalities in Tbx3-/- embryos were not observed
between E8.5 and E9.25, which is in agreement with previous
work [18]. The only abnormality seen in yolks sac or gross
placental morphology was a reduction in yolk sac vasculature
in 1 of 4 Tbx20+/-; Tbx3-/- embryos at E8.5 and 1 of 6 double
homozygous mutant embryos at E9.25 (Table 3). This
resembled the reduced vasculature reported for Tbx3-/- and
Tbx20-/- embryos at E9.5 [3,18].
Developmental delay in Tbx3-/- and Tbx20-/-; Tbx3-/-
embryos
Among the embryos from Tbx20+/-; Tbx3+/- double
heterozygous crosses at E8.5, some single or double
homozygous embryos showed developmental delay, but over
90% were living (65/71) (Table 2); by E9.25, however, 37%
(7/19) were dead (Table 3). Thus, to assess the extent of
developmental delay associated with each genotype prior to
death, we scored living embryos at E8.5 (n=160) using somite
number to determine developmental stage. To account for
between-litter variation, the ratio of the number of somites for
an embryo to the mean number of somites in its litter was
calculated for each embryo. A Mann Whitney U test showed
that there is no significant difference in this ratio between
Tbx20-/- homozygous mutants and Tbx20-/-; Tbx3+/- compound
Figure 1.  Tbx20-/-; Tbx3-/- double homozygotes show heart defects similar to Tbx20-/- embryos.  Whole mount ventral (A–F)
and left side (G, H) views of the heart (E9.25; 15-20 somite embryos) of Tbx20; Tbx3 single, compound and double mutants
compared with wild type (D, H). All Tbx20-/- embryos have an unlooped, hourglass-shaped heart (A-C, outlined in A), whereas Tbx3-/-
embryos either wild type or heterozygous for Tbx20 (E, F, G) have normally looped hearts but show atrioventricular convergence
defects (G, arrows) compared with wild type (H). lv, left ventricle; rv, right ventricle; t, telencephalon.
doi: 10.1371/journal.pone.0070149.g001
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mutant embryos, nor between Tbx3-/- homozygous mutants and
Tbx20+/-; Tbx3-/- compound mutants. Thus, single and
compound mutants were combined and the distributions of
ratios for embryos of each group were compared using notched
box plots (Figure 2). The analysis showed that both Tbx20-/-;
Tbx3-/- double homozygotes and Tbx3-/- mutants are
significantly delayed developmentally compared to wild type or
Tbx20-/- embryos, but are similar to one another. Thus, with
respect to developmental delay, Tbx20-/-; Tbx3-/- embryos
resemble Tbx3-/- embryos (Figure 2).
Cardiac gene expression in Tbx20-/-; Tbx3-/- embryos
Molecular markers of cardiac development were used to
further characterize the phenotype of compound and double
homozygous mutant embryonic hearts. Tbx2 is normally
expressed in the non-chamber myocardium, most prominently
in the AVC. As previously reported [14], Tbx2 expression was
not altered in Tbx20-/- hearts at E8.75 (data not shown) but was
upregulated and ectopically expressed throughout the entire
Tbx20-/- mutant heart by E9.25. Similar upregulation and
ectopic expression of Tbx2 was seen in Tbx20-/-; Tbx3-/- double
homozygous mutant hearts, whereas expression in Tbx3-/-
hearts was normal (Figure 3A–D).
Expression of Nppa, a marker of chamber myocardium and a
target of both Tbx20 and Tbx3, was severely down regulated in
both Tbx20-/- and double homozygous mutant hearts from E8.5-
E9.25, demonstrating the lack of chamber differentiation. In
contrast, precocious expression of Nppa in atrial myocardium
was observed in Tbx3-/- embryos, as previously described [19]
(Figure 3E–H), as well as in Tbx20+/-; Tbx3-/- compound
mutants (data not shown).
We observed no change in expression of Pitx2, which is
important for cardiac remodeling and asymmetric development,
in the left inflow tract (IFT) of Tbx20-/-, Tbx3-/- or Tbx20-/-; Tbx3-/-
embryos compared to stage-matched wild type controls (Figure
Table 2. Frequency of different morphological defects in embryos at E8.5 from matings of Tbx20+/-; Tbx3+/- double
heterozygotes*.
  Genotypes
Stage Morphology wt** Tbx20-/-; Tbx3+/+ Tbx20-/-; Tbx3+/- Tbx20+/+;Tbx3-/- Tbx20+/-; Tbx3-/- Tbx20-/-; Tbx3-/-
E8.5 Normal 89 3*** 2*** 1*** 0 1***
 Abnormal. looping 0 14 14 0 0 0
 Abnormal looping / delay 0 3 3 0 0 3
 Abnormal looping / dead 0 2 0 0 0 0
 Delay 6 1 6 7 4## 3
 Dead# 1 0 3 0 0 1
Total (n=167)  96 23 28 8 4 8
*. Double heterozygotes were either intercrossed or crossed to single heterozygotes.
**. wt, wild type; this group includes wild type and heterozygotes for one or both alleles.
***. Embryos were at the cardiac crescent stage, prior to heart looping.
#. Approximate time of death between E8.0 and E8.5; too degenerate to score for heart phenotype.
##. One of these embryos had a yolk sac defect.
Table 3. Frequency of different morphological defects in embryos at E9.25 from matings of Tbx20+/-; Tbx3+/- double
heterozygotes*.
  Genotypes
Stage Morphology wt** Tbx20-/-; Tbx3+/+ Tbx20-/-; Tbx3+/- Tbx20+/+;Tbx3-/- Tbx20+/-; Tbx3-/- Tbx20-/-; Tbx3-/-
E9.25 Normal 23 0 0 0 0 0
 Abnormal looping 0 0 0 0 0 1
 Abnormal looping / delay 0 1 1 0 0 4***
 Abnormal convergence 0 0 0 1 0 0
 Abnormal convergence /delay 0 0 0 2 1 0
 Abnormal convergence / dead 0 0 0 1 1 0
 Delay 0 0 0 0 1 0
 Dead# 1 3 0 0 1 1
Total (n=43)  24 4 1 4 4 6
*. Double heterozygotes were either intercrossed or crossed to single heterozygotes.
**. wt, wild type; this group includes wild type and heterozygotes for one or both alleles.
***. One of these embryos had a yolk sac defect.
#. Approximate time of death between E8.75-E9.0; too degenerate to score for heart phenotype.
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3I–L). Tbx5, which is expressed in the atrioventricular and atrial
progenitors in an antero-posterior gradient, was slightly
reduced in both Tbx20-/- and Tbx20-/-; Tbx3-/- embryos at E8.5
but no difference in expression was evident among the
genotypes by E9.25 (Figure 3M–O).
Discussion
The DNA binding domain of T-box proteins, as well as T-box
binding motifs identified in the promoters of downstream target
genes, are highly conserved. This leads to the possibility that
these transcription factors have targets in common and could
compete or cooperate in transcriptional regulation of specific
targets in areas of overlapping gene expression. Furthermore,
some T-box proteins can bind DNA as dimers, raising the
possibility of heterodimerization. In the developing heart at
least seven T-box genes are expressed [1,23] and although
each has a specific pattern of expression, there are extensive
areas of expression overlap. Genetic studies have shown that
some of these genes do indeed interact during heart
development. Tbx1, Tbx2 and Tbx3 all interact in OFT
development with Tbx1 upstream of Tbx2 and Tbx3. Double
homozygous mutants for Tbx1 with either Tbx2 or Tbx3 have
heart failure more severe than either single mutant alone [24].
At the level of gene regulation, Tbx2 and Tbx5 have been
shown to repress or activate, respectively the expression of
Figure 2.  Tbx20-/-; Tbx3-/- double homozygotes are
developmentally delayed as are Tbx3-/- embryos.  Notched
box plots showing the distributions of the ratio of somite
number in an embryo / the mean somite number for the litter in
four different groups: wild type, Tbx20-/- homozygous mutants;
Tbx3-/- homozygous mutants and double homozygotes.
Compound and single mutants were combined for this
comparison as single mutants were not different from the
compounds (Mann Whitney U test). Whiskers of the notched
box plots represent 10th and 90th percentiles, boxes include
the 25th through 75th percentile, and outliers are individually
plotted. If the notches of two plots do not overlap, this indicates
that the medians differ between the two. With respect to
developmental stage, Tbx20-/-; Tbx3-/- double homozygotes
resemble Tbx3-/- embryos and both groups are delayed
compared to wild type or Tbx20-/- embryos.
doi: 10.1371/journal.pone.0070149.g002
Nppa through competing interactions with the transcriptional
co-factor Nkx2-5 [25–27]. Tbx3 and Tbx20 have also been
shown capable of interacting with Nkx2-5 [12,17]. T-box genes
might also regulate one another and in this respect, Tbx20 has
been shown to repress Tbx2 expression in the developing
heart, as in its absence, Tbx2 is upregulated throughout the
chamber myocardium of the heart tube [3].
Tbx20 and Tbx3 have areas of overlapping expression in the
OFT and AVC of the developing heart and thus have the
potential to interact either by affecting common downstream
target genes or by cross regulation. A potential example of
cross regulation was noted in Tbx3 mutant hearts at
E13.5-14.5 where Tbx20, which is normally expressed in the
base of the developing interventricular septum, appears to be
ectopically expressed in the developing conduction system at
the apex of the septum where Tbx3 would normally be
expressed [10]. However, whether this is genuine ectopic
expression or simply the lack of Tbx3-expressing tissue in the
abnormally developing septum is not clear. On the other hand,
Tbx20 regulates Tbx3 in the AVC as deletion of Tbx20
specifically in the AVC leads to a downregulation of Tbx3
expression at E9.5 [21].
To investigate the phenotypic consequences of possible
interactions between the two genes at the earliest stages of
heart development, we produced double mutants using mutant
alleles that ablate function and compared the morphological
and molecular phenotypes of the single, compound and double
mutants. We found no evidence for a genetic interaction in
double heterozygotes, which were viable and fertile, or in
double homozygotes, which displayed an embryonic heart
phenotype indistinguishable from Tbx20 single homozygous
mutants: morphologically the double homozygous mutant
hearts displayed a vertically oriented hourglass shaped, two-
chambered heart with no looping. Molecularly, Tbx2 was
upregulated throughout the heart tube and Nppa was severely
down regulated in the double homozygous mutants, similar to
Tbx20 single mutants, whereas Pitx2 and Tbx5 were
unchanged. This phenotype is indistinguishable from the
Tbx20-/- phenotype where cardiac development is arrested and
chamber differentiation does not occur although the anterior/
posterior and left/right axes are established correctly. Because
of this early arrest starting at E8.5, cardiac development never
reached the stage where phenotypic features characteristic of
the Tbx3 mutant heart, such as convergence defects,
increased AVC cell proliferation and ventricular septal defects,
could be evaluated. Thus, Tbx20 is epistatic to Tbx3 with
respect to the early heart phenotype and heart development is
arrested at an earlier developmental stage than the Tbx3
phenotype becomes manifest. To further investigate potential
genetic interactions in the cardiac conduction system,
conditional alleles that allow survival beyond the time of death
of the homozygous mutants would be required. For this type of
study, the recently developed Tbx3 allelic series, which has
been used to demonstrate exquisite dose sensitivity of the
cardiac conduction system to levels of Tbx3 in embryos and
adults could be combined with a conditional Tbx20 allele to test
for genetic interactions throughout development and adult life
[28]. It has been previously reported that Tbx3 homozygous
Tbx20 and Tbx3 in Early Mouse Heart Development
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mutant embryos are delayed in their overall development
compared with littermates [18]. We observed a similar
developmental delay in Tbx20-/-; Tbx3-/- double homozygous
embryos that was not seen in Tbx20 single mutants. Thus,
developmental delay is associated with the Tbx3 mutant
genotype, even though Tbx20 mutants have a more severe
Figure 3.  Cardiac marker gene expression suggests that Tbx20-/-; Tbx3-/- double homozygous mutants show a Tbx20-/-
phenotype.  Whole mount ISH left (A–H) or ventral (I–O) views of the head and heart of stage-matched wild type, single and double
mutant embryos showing expression of Tbx2 (E9.25; A-D), Nppa (E9.25; E-H), Pitx2 (E8.5; I-L) and Tbx5 (E9.25; M-O). Tbx2 is
normally expressed in the AVC in wild type and Tbx3-/- hearts but is ectopically expressed in Tbx20-/- and double homozygotes. In
Tbx20-/- and double homozygotes, Nppa expression is severely down regulated in ventricular myocardium, but in Tbx3-/- hearts it is
precociously upregulated in atrial myocardium. There is no change in Pitx2 expression in the left inflow tract in Tbx20-/-, Tbx3-/- or
double homozygous embryos when compared to wild type. Tbx5 is expressed in the atrioventricular and atrial progenitors in an
antero-posterior gradient. There is no change in Tbx5 expression in either Tbx20-/- or double homozygotes compared to wild type at
E9.25. at, atrium; AVC, atrioventricular canal; h, heart; IFT, inflow tract; lt IFT, left inflow tract; t, telencephalon; v, ventricle.
doi: 10.1371/journal.pone.0070149.g003
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and earlier heart abnormality. It was previously postulated that
vascular defects and apoptosis in the Tbx3 mutant yolk sac
were responsible for this developmental delay [18], even
though the subsequent discovery of a heart phenotype put this
interpretation into question [19]. Both Tbx3 and Tbx20 are
expressed in the yolk sac, Tbx20 in the mesoderm layer [3] and
Tbx3 in both endoderm and mesoderm [29], and vascular
deficiency has been reported in both single mutants at E9.5
[3,18]. In this study of E8.5-9.25 embryos, the incidence of
abnormal yolk sac vasculature was very low in Tbx3 mutants
and was not exacerbated in double mutants. Thus the
developmental delay associated with the Tbx3 mutant
genotype does not appear to be associated with an early yolk
sac vasculature phenotype and remains to be elucidated.
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